Industry News

AbbVie Announces U.S. FDA Approval of DUOPA� (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease -- DUOPA is the first and only treatment providing 16 continuous hours
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals
Rep. Scott Peters Fights to Repeal Medical Device Tax Rep. Scott Peters (D-CA) News Release
Daiichi Sankyo's anti-clotting drug Savaysa gets FDA approval
Daiichi Sankyo's anti-clotting drug Savaysa gets FDA approval
US FDA LENS ON CHINA BAD NEWS FOR INDIAN DRUG COMPANIES
Impax Pharmaceuticals Announce FDA Approval of RYTARY Extended-Release Capsules for the Treatment of Parkinson's disease
Patent Issued for Aseptically Packaged Nutritional Liquids Comprising HMB Pharmaceutical Companies
Command Medical doubles cleanroom space in Nicaragua
BIO Urges FDA to Release Guidance on Biosimilars
The BD Intelliport Medication Management System Receives Clearance from the Food and Drug Administration (FDA)
Command Medical doubles cleanroom space in Nicaragua
The BD Intelliport Medication Management System Receives Clearance from the Food and Drug Administration (FDA)
Symic Biomedical Announces Collaboration with Nordic Biosciences for its Osteoarthritis Program -- Strategic partnership to focus on development and execution of clinical trial programs through FDA approval-- Initial clinical study in osteoarthritis of th
Fresenius Kabi introduces NAROPIN in Freeflex Bag
FDA approves Bayer's Gadavist injection as the first magnetic resonance contrast agent for pediatric patients less than 2 years of age
Valeant Pharmaceuticals North America LLC Issues Voluntary Recall of Virazole (ribavirin powder for solution) in the United States
Innovate Biopharmaceuticals Acquires Late-Stage Pancreatic Imaging Assets Company Plans to Augment Phase 3 Clinical Data Package to Support Potential Product Approval
RIVA a Key Component of Licensed Manufacturing Process for Chemotherapy Drugs in Australia
FDA approves Bayer's Gadavist� (gadobutrol) injection as the first magnetic resonance contrast agent for pediatric patients less than 2 years of age -- Expanded use of Gadavist is specific to detecting and visualizing areas with disrupted blood
Medtronic Drug-Coated Balloon Receives FDA Approval for Treating Peripheral Artery Disease in Upper Leg
Pfizer continues vaccine push, buys Switzerland's Redvax
China to triple patents by 2020
Advaxis Submits Investigational New Drug Application to FDA for ADXS-HER2 Following FDA Review Company to Initiate Clinical Trial for the Treatment of HER2 Expressing Solid-Tumors
Health advocates seek regulations on e-cigarettes from Multnomah County